在患有帕金森病的人群中,增强现实提示的步态修饰效应
Eva M Hoogendoorn1, Daphne J Geerse1, Annejet T van Dam1
1Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, Netherlands.
Frontiers in neurology
|April 24, 2024
概括
增强现实 (AR) 线索有效地改善了帕金森病 (PD) 患者的步态,与现实世界的线索性能相匹配. AR耳机视野大小没有影响步态修改,显示AR耳机视野大小没有影响步态修改,显示AR.
科学领域:
- 神经科学和生物医学工程
- 人与计算机的交互
背景情况:
- 外部暗示策略,特别是视觉暗示,在改善帕金森病 (PD) 患者的步态方面表现有前途.
- 需要先进的,可穿戴和个性化的提示技术,利用与行动相关的视觉信息.
- 增强现实 (AR) 为提供灵活和个性化的视觉线索提供了一个潜在的解决方案.
研究的目的:
- 研究PD患者的现实世界视觉线索与增强现实 (AR) 线索对步态修改的影响.
- 评估AR耳机视野 (AR-FOV) 尺寸对步态修改和用户头部方向的影响.
- 评估AR技术在改善PD患者的步态参数方面的有效性.
主要方法:
- 21名患有PD的参与者在现实世界和AR提示条件下执行了行走任务.
- 测量了步行参数,包括速度,步骤长度,交叉步骤长度和步骤高度.
- 用了两种不同的AR-FOV大小的AR耳机来检查潜在的FOV相关影响.
主要成果:
- 参与者显著改变了步行速度,步长和跨越步长,以应对现实世界和AR线索.
- 响应AR线索的步态修改在统计学上相当于因现实世界线索引起的步态修改.
- AR-FOV大小没有显著影响步态修改,尽管在头部方向上发现了微小的差异.
结论:
- 最先进的AR耳机使得PD患者能够使用AR线索有效地修改他们的步态,与现实世界线索相似.
- AR-FOV大小不是基于AR的PD步态提示的限制因素.
- 进一步的研究应该探索多样化的提示模式和个性化的AR提示,用于PD的现实世界步行康复.
更多相关视频
04:08Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
2.8K
05:54A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
158
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
